Selected research
Industry Research
Children's DHA Industry Research Report 2026
Market perspective
The global Children's DHA market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Children's DHA is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Children's DHA is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Children's DHA is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Children's DHA include By-Health, Shanghai Pharmaceuticals, Neuromins, CABIO, DSM-Firmenich, Wyeth, Nordic Naturals, Nature's Way and Hero Nutritonals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Children's DHA market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Children's DHA Market by Company
By-Health
Shanghai Pharmaceuticals
Neuromins
CABIO
DSM-Firmenich
Wyeth
Nordic Naturals
Nature's Way
Hero Nutritonals
GNC
Bioisland
Amway
Children's DHA Segment by Type
Egg Yolk DHA
Fish Oil DHA
Algae Oil DHA
Children's DHA Segment by Application
Online Sales
Offline Sales
Children's DHA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children's DHA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Children's DHA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children's DHA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Children's DHA manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Children's DHA by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Children's DHA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Egg Yolk DHA
- Fish Oil DHA
- Algae Oil DHA
Applications
- Online Sales
- Offline Sales
Companies covered
- By-Health
- Shanghai Pharmaceuticals
- Neuromins
- CABIO
- DSM-Firmenich
- Wyeth
- Nordic Naturals
- Nature's Way
- Hero Nutritonals
- GNC
- Bioisland
- Amway
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Children's DHA Market Size (2021-2032)
- 2.2.2 Global Children's DHA Sales (2021-2032)
- 2.2.3 Global Children's DHA Market Average Price (2021-2032)
- 2.3 Children's DHA by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Egg Yolk DHA
- 2.3.3 Fish Oil DHA
- 2.3.4 Algae Oil DHA
- 2.4 Children's DHA by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Children's DHA Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Children's DHA Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Children's DHA Revenue of Manufacturers (2021-2026)
- 3.4 Global Children's DHA Average Price by Manufacturers (2021-2026)
- 3.5 Global Children's DHA Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Children's DHA, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Children's DHA, Product Type & Application
- 3.8 Global Manufacturers of Children's DHA, Established Date
- 3.9 Global Children's DHA Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 By-Health
- 4.1.1 By-Health Company Information
- 4.1.2 By-Health Business Overview
- 4.1.3 By-Health Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 By-Health Children's DHA Product Portfolio
- 4.1.5 By-Health Recent Developments
- 4.2 Shanghai Pharmaceuticals
- 4.2.1 Shanghai Pharmaceuticals Company Information
- 4.2.2 Shanghai Pharmaceuticals Business Overview
- 4.2.3 Shanghai Pharmaceuticals Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Pharmaceuticals Children's DHA Product Portfolio
- 4.2.5 Shanghai Pharmaceuticals Recent Developments
- 4.3 Neuromins
- 4.3.1 Neuromins Company Information
- 4.3.2 Neuromins Business Overview
- 4.3.3 Neuromins Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Neuromins Children's DHA Product Portfolio
- 4.3.5 Neuromins Recent Developments
- 4.4 CABIO
- 4.4.1 CABIO Company Information
- 4.4.2 CABIO Business Overview
- 4.4.3 CABIO Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CABIO Children's DHA Product Portfolio
- 4.4.5 CABIO Recent Developments
- 4.5 DSM-Firmenich
- 4.5.1 DSM-Firmenich Company Information
- 4.5.2 DSM-Firmenich Business Overview
- 4.5.3 DSM-Firmenich Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 DSM-Firmenich Children's DHA Product Portfolio
- 4.5.5 DSM-Firmenich Recent Developments
- 4.6 Wyeth
- 4.6.1 Wyeth Company Information
- 4.6.2 Wyeth Business Overview
- 4.6.3 Wyeth Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Wyeth Children's DHA Product Portfolio
- 4.6.5 Wyeth Recent Developments
- 4.7 Nordic Naturals
- 4.7.1 Nordic Naturals Company Information
- 4.7.2 Nordic Naturals Business Overview
- 4.7.3 Nordic Naturals Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nordic Naturals Children's DHA Product Portfolio
- 4.7.5 Nordic Naturals Recent Developments
- 4.8 Nature's Way
- 4.8.1 Nature's Way Company Information
- 4.8.2 Nature's Way Business Overview
- 4.8.3 Nature's Way Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nature's Way Children's DHA Product Portfolio
- 4.8.5 Nature's Way Recent Developments
- 4.9 Hero Nutritonals
- 4.9.1 Hero Nutritonals Company Information
- 4.9.2 Hero Nutritonals Business Overview
- 4.9.3 Hero Nutritonals Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hero Nutritonals Children's DHA Product Portfolio
- 4.9.5 Hero Nutritonals Recent Developments
- 4.10 GNC
- 4.10.1 GNC Company Information
- 4.10.2 GNC Business Overview
- 4.10.3 GNC Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GNC Children's DHA Product Portfolio
- 4.10.5 GNC Recent Developments
- 4.11 Bioisland
- 4.11.1 Bioisland Company Information
- 4.11.2 Bioisland Business Overview
- 4.11.3 Bioisland Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bioisland Children's DHA Product Portfolio
- 4.11.5 Bioisland Recent Developments
- 4.12 Amway
- 4.12.1 Amway Company Information
- 4.12.2 Amway Business Overview
- 4.12.3 Amway Children's DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Amway Children's DHA Product Portfolio
- 4.12.5 Amway Recent Developments
5 Global Children's DHA Market Scenario by Region
- 5.1 Global Children's DHA Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Children's DHA Sales by Region: 2021-2032
- 5.2.1 Global Children's DHA Sales by Region: 2021-2026
- 5.2.2 Global Children's DHA Sales by Region: 2027-2032
- 5.3 Global Children's DHA Revenue by Region: 2021-2032
- 5.3.1 Global Children's DHA Revenue by Region: 2021-2026
- 5.3.2 Global Children's DHA Revenue by Region: 2027-2032
- 5.4 North America Children's DHA Market Facts & Figures by Country
- 5.4.1 North America Children's DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Children's DHA Sales by Country (2021-2032)
- 5.4.3 North America Children's DHA Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Children's DHA Market Facts & Figures by Country
- 5.5.1 Europe Children's DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Children's DHA Sales by Country (2021-2032)
- 5.5.3 Europe Children's DHA Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Children's DHA Market Facts & Figures by Country
- 5.6.1 Asia Pacific Children's DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Children's DHA Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Children's DHA Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Children's DHA Market Facts & Figures by Country
- 5.7.1 South America Children's DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Children's DHA Sales by Country (2021-2032)
- 5.7.3 South America Children's DHA Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Children's DHA Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Children's DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Children's DHA Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Children's DHA Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Children's DHA Sales by Type (2021-2032)
- 6.1.1 Global Children's DHA Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Children's DHA Sales Market Share by Type (2021-2032)
- 6.2 Global Children's DHA Revenue by Type (2021-2032)
- 6.2.1 Global Children's DHA Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Children's DHA Revenue Market Share by Type (2021-2032)
- 6.3 Global Children's DHA Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Children's DHA Sales by Application (2021-2032)
- 7.1.1 Global Children's DHA Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Children's DHA Sales Market Share by Application (2021-2032)
- 7.2 Global Children's DHA Revenue by Application (2021-2032)
- 7.2.1 Global Children's DHA Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Children's DHA Revenue Market Share by Application (2021-2032)
- 7.3 Global Children's DHA Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Children's DHA Value Chain Analysis
- 8.1.1 Children's DHA Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Children's DHA Production Mode & Process
- 8.2 Children's DHA Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Children's DHA Distributors
- 8.2.3 Children's DHA Customers
9 Global Children's DHA Analyzing Market Dynamics
- 9.1 Children's DHA Industry Trends
- 9.2 Children's DHA Industry Drivers
- 9.3 Children's DHA Industry Opportunities and Challenges
- 9.4 Children's DHA Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst